Search research articles
Contact Us
Filters
Showing results (181-190 of 209) with videos related to
Page
of 21
Sort By:
The New England Journal of Medicine
|
March 22, 2018
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Robert J Motzer, Nizar M Tannir, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2020
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer
Judit Börcsök, Zsofia Sztupinszki, Raie Bekele, et al.
Cancer
|
July 17, 2020
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial
Robert J Motzer, Bernard Escudier, Saby George, et al.
JCO Precision Oncology
|
June 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
Uttam Satyal, Henkel Valentine, David Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 17, 2013
Prostate cancer, version 1.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 19, 2015
Testicular Cancer, Version 2.2015
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 19, 2015
Kidney cancer, version 3.2015
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 209) with videos related to
Sort By:
Page
of 21
The New England Journal of Medicine
|
March 22, 2018
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Robert J Motzer, Nizar M Tannir, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2016
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
Noah M Hahn, Trinity J Bivalacqua, Ashley E Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2020
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer
Judit Börcsök, Zsofia Sztupinszki, Raie Bekele, et al.
Cancer
|
July 17, 2020
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial
Robert J Motzer, Bernard Escudier, Saby George, et al.
JCO Precision Oncology
|
June 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
Uttam Satyal, Henkel Valentine, David Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 17, 2013
Prostate cancer, version 1.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 19, 2015
Testicular Cancer, Version 2.2015
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 19, 2015
Kidney cancer, version 3.2015
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Page
of 21